Ian J. Davis

27.7k total citations · 1 hit paper
117 papers, 9.6k citations indexed

About

Ian J. Davis is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ian J. Davis has authored 117 papers receiving a total of 9.6k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Molecular Biology, 13 papers in Oncology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ian J. Davis's work include Genomics and Chromatin Dynamics (23 papers), RNA Research and Splicing (14 papers) and Oral microbiology and periodontitis research (12 papers). Ian J. Davis is often cited by papers focused on Genomics and Chromatin Dynamics (23 papers), RNA Research and Splicing (14 papers) and Oral microbiology and periodontitis research (12 papers). Ian J. Davis collaborates with scholars based in United States, United Kingdom and Canada. Ian J. Davis's co-authors include Piers Blaikie, Terry Cannon, Benjamin Wisner, Lester F. Lau, David E. Fisher, Jeremy M. Simon, Jason D. Lieb, Paul G. Giresi, Thomas G. Hazel and Marc Ladanyi and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Ian J. Davis

116 papers receiving 8.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

At Risk: Natural Hazards, People's Vulnerability and Disasters

1994 4.5k citations Ian J. Davis et al. profile →

Peers

Countries citing papers authored by Ian J. Davis

Since Specialization

Citations

This map shows the geographic impact of Ian J. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian J. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian J. Davis more than expected).

Fields of papers citing papers by Ian J. Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian J. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian J. Davis. The network helps show where Ian J. Davis may publish in the future.

Co-authorship network of co-authors of Ian J. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Ian J. Davis. A scholar is included among the top collaborators of Ian J. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian J. Davis. Ian J. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A SETD2–CDK1–lamin axis maintains nuclear morphology and genome stability 2025 ·Nature Cell Biology ·Abid Khan, Cheng Zhang, Phu Hung Nguyen, (unknown), (unknown), Kanishk Jain, Christine A. Mills, (unknown), Kelin Li, (unknown), Brittany M. Bowman, Michael B. Major, Jeffrey Aubé, Laura E. Herring, W. Kimryn Rathmell, Frank M. Mason, Ian J. Davis, Qing Zhang, Brian D. Strahl	1
2	Type II innate lymphoid cell plasticity contributes to impaired reconstitution after allogeneic hematopoietic stem cell transplantation 2024 ·Nature Communications ·Sonia J. Laurie, (unknown), Danny Bruce, Hemamalini Bommiasamy, (unknown), Mostafa Yazdimamaghani, Samantha G. Pattenden, Nelson J. Chao, Stefanie Sarantopoulos, Joel S. Parker, Ian J. Davis, Jonathan S. Serody	4
3	Co-targeting JAK1/STAT6/GAS6/TAM signaling improves chemotherapy efficacy in Ewing sarcoma 2024 ·Nature Communications ·Le Yu, Yu Deng, Xiaodong Wang, Charlene Santos, Ian J. Davis, H. Shelton Earp, Pengda Liu	4
4	Regulation of EWSR1-FLI1 Function by Post-Transcriptional and Post-Translational Modifications 2023 ·Cancers ·Le Yu, Ian J. Davis, Pengda Liu	14
5	Radiation-Induced Phosphorylation of a Prion-Like Domain Regulates Transformation by FUS-CHOP 2021 ·Cancer Research ·Mark Chen, (unknown), (unknown), (unknown), Andrea R. Daniel, (unknown), Eric S. Xu, Ian J. Davis, David G. Kirsch	6
6	Genome-wide cancer-specific chromatin accessibility patterns derived from archival processed xenograft tumors 2021 ·Genome Research ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), James K. Tsuruta, Sandeep K. Kasoji, Charlene Santos, Paul A. Dayton, Joel S. Parker, Ian J. Davis, Samantha G. Pattenden	4
7	Discrete Adaptive Responses to MEK Inhibitor in Subpopulations of Triple-Negative Breast Cancer 2020 ·Molecular Cancer Research ·Daniel R. Goulet, (unknown), Jon S. Zawistowski, Samantha M. Bevill, (unknown), (unknown), Noah Sciaky, Darshan Singh, Charlene Santos, Samantha G. Pattenden, Ian J. Davis, Gary L. Johnson	3
8	An optogenetic switch for the Set2 methyltransferase provides evidence for transcription-dependent and -independent dynamics of H3K36 methylation 2020 ·Genome Research ·(unknown), Austin J. Hepperla, Gregory R. Keele, (unknown), Hayretin Yumerefendi, David Restrepo, Seth P. Zimmerman, James E. Bear, Brian Kuhlman, Ian J. Davis, Brian D. Strahl	13
9	Radiation Sensitivity in a Preclinical Mouse Model of Medulloblastoma Relies on the Function of the Intrinsic Apoptotic Pathway 2016 ·Cancer Research ·Andrew Crowther, (unknown), Fang Fang, (unknown), (unknown), Allison M. Deal, S Chang, Hong Yuan, Ralf S. Schmid, Ian J. Davis, Timothy R. Gershon	22
10	BRG1/SMARCA4 Inactivation Promotes Non–Small Cell Lung Cancer Aggressiveness by Altering Chromatin Organization 2014 ·Cancer Research ·(unknown), Austin J. Hepperla, Vonn Walter, Shujie Song, Jeremy M. Simon, Joel S. Parker, Matthew D. Wilkerson, Nisarg Desai, Michael B. Major, D. Neil Hayes, Ian J. Davis, Bernard E. Weissman	102
11	PTEN Deficiency Mediates a Reciprocal Response to IGFI and mTOR Inhibition 2014 ·Molecular Cancer Research ·(unknown), Nicholas C. Gomez, Andrew W. McFadden, Billie M. Moats‐Staats, Sam Wu, Andrés Rojas, (unknown), Jeremy M. Simon, (unknown), Kathleen Kaiser‐Rogers, Ian J. Davis	26
12	Variation in chromatin accessibility in human kidney cancer links H3K36 methyltransferase loss with widespread RNA processing defects 2013 ·Genome Research ·Jeremy M. Simon, Kathryn E. Hacker, Darshan Singh, A. Rose Brannon, Joel S. Parker, Matthew Weiser, Thai H. Ho, Pei Fen Kuan, Eric Jonasch, Terrence S. Furey, Jan F. Prins, Jason D. Lieb, W. Kimryn Rathmell, Ian J. Davis	137
13	Identification of the Receptor Tyrosine Kinase c-Met and Its Ligand, Hepatocyte Growth Factor, as Therapeutic Targets in Clear Cell Sarcoma 2010 ·Cancer Research ·Ian J. Davis, Andrew W. McFadden, Yixiang Zhang, Angela Coxon, Teresa L. Burgess, Andrew J. Wagner, David E. Fisher	88
14	Antimalarial Therapy Selection for Quinolone Resistance among Escherichia coli in the Absence of Quinolone Exposure, in Tropical South America 2008 ·PLoS ONE ·Ross Davidson, Ian J. Davis, Barbara Willey, (unknown), Shelly Bolotin, (unknown), Jane Y. Polsky, Nick Daneman, Allison McGeer, Paul Yang, Dennis Scolnik, (unknown), (unknown), Michael Silverman	23
15	TFE3 Fusions Activate MET Signaling by Transcriptional Up-regulation, Defining Another Class of Tumors as Candidates for Therapeutic MET Inhibition 2007 ·Cancer Research ·Masumi Tsuda, Ian J. Davis, Pedram Argani, Neerav Shukla, Gaël McGill, Makoto Nagai, Tsuyoshi Saito, Marick Laé, David E. Fisher, Marc Ladanyi	217
16	Search for Principles of Disaster Management 2007 ·David Etkin, Ian J. Davis	1
17	Use of an interferon-gamma based assay to assess bladder cancer patients treated with intravesical BCG and exposed to tuberculosis 2007 ·Clinical Biochemistry ·Michael Silverman, Donna L. Reynolds, Peter A. Kavsak, Jone Garay, Andrew Daly, Ian J. Davis	10
18	Nur77 Is Differentially Modified in PC12 Cells upon Membrane Depolarization and Growth Factor Treatment 1991 ·Molecular and Cellular Biology ·Thomas G. Hazel, Ravi Misra, Ian J. Davis, Michael E. Greenberg, Lester F. Lau	94
19	Safe shelter within unsafe cities : Disaster vulnerability and rapid urbanisation 1987 ·Open House International ·Ian J. Davis	6
20	Lice Earthquake in Southeastern Turkey - Geography of Disaster 1978 ·Disasters ·Ian J. Davis	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact